Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2014 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
Pediatrics. 2014 Oct;134(4):e1104-16. doi: 10.1542/peds.2014-0527.
Pediatrics. 2014.
PMID: 25266426
Free PMC article.
Clinical Trial.
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
PENPACT-1 (PENTA 9/PACTG 390) Study Team; Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibb DM, Harper L, Harrison L, Hughes M, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS.
PENPACT-1 (PENTA 9/PACTG 390) Study Team, et al.
Lancet Infect Dis. 2011 Apr;11(4):273-83. doi: 10.1016/S1473-3099(10)70313-3. Epub 2011 Jan 31.
Lancet Infect Dis. 2011.
PMID: 21288774
Free PMC article.
Clinical Trial.
Item in Clipboard
Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors.
Yin DE, Ludema C, Cole SR, Golin CE, Miller WC, Warshaw MG, McKinney RE Jr; PENPACT-1 (PENTA 9 / PACTG 390) Study Team.
Yin DE, et al.
PLoS One. 2020 Nov 23;15(11):e0242405. doi: 10.1371/journal.pone.0242405. eCollection 2020.
PLoS One. 2020.
PMID: 33226999
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.